Dually-targeted liposomes curb triple-negative breast cancer, metastases in mice
Some 15 to 20 percent of all breast cancers are triple-negative, meaning they lack receptors for estrogen, progesterone and human epidermal growth factor type 2. They have the worst prognosis of all breast cancers and very limited treatment options. Finding a treatment that distinguishes between cancer cells and normal cells has been especially challenging. A ... Read More about Dually-targeted liposomes curb triple-negative breast cancer, metastases in mice
Drug repurposing and DNA mining: The hunt for new endometriosis treatments
Endometriosis is a common gynecological condition that may affect more than 1 in 10 reproductive-age women. Yet, there’s very little research into the disease and limited options for treatment. A team in the Vascular Biology Program at Boston Children’s Hospital is trying to change that. In endometriosis, tissue that normally grows inside the uterus grows outside of ... Read More about Drug repurposing and DNA mining: The hunt for new endometriosis treatments
CRISPR-Cas9 screen opens new targets for Ewing sarcoma, other childhood cancers
While the genetic mutations driving adult cancers can sometimes be targeted with drugs, most pediatric cancers lack good targets. That’s because their driving genetic alterations often create fusion proteins that aren’t easy for drugs to attack. “This is one reason why it is notoriously hard to make targeted drugs against childhood cancers — their cancer-promoting ... Read More about CRISPR-Cas9 screen opens new targets for Ewing sarcoma, other childhood cancers
After 80 years, genetic causes of Diamond-Blackfan anemia come into view
In 1938, Louis K. Diamond, MD, and Kenneth Blackfan, MD, at Boston Children’s Hospital described a severe congenital anemia that they termed “hypoplastic” (literally, “underdeveloped”) because of the bone marrow’s inability to produce mature, functioning red blood cells. Eighty years later, the multiple genetic origins of this highly rare disease, now known as Diamond-Blackfan anemia, or ... Read More about After 80 years, genetic causes of Diamond-Blackfan anemia come into view
New angles for blocking Shiga and ricin toxins, and new light on an iconic biological process
Min Dong, PhD, and his lab are world experts in toxins and how to combat them. They’ve figured out how Clostridium difficile’s most potent toxin gets into cells and zeroed in on the first new botulinum toxin identified since 1969. Now, they’ve set their sights on Shiga and ricin toxins, and not only identified new potential lines of defense, ... Read More about New angles for blocking Shiga and ricin toxins, and new light on an iconic biological process
Synapse ‘protection’ signal found; helps to refine brain circuits
The developing brain is constantly forming new connections, or synapses, between nerve cells. Many connections are eventually lost, while others are strengthened. In 2012, Beth Stevens, PhD and her lab at Boston Children’s Hospital showed that microglia, immune cells that live in the brain, prune back unwanted synapses by engulfing or “eating” them. They also ... Read More about Synapse ‘protection’ signal found; helps to refine brain circuits
Earlier treatment may help reverse autism-like behavior in tuberous sclerosis
New research on autism has found, in a mouse model, that drug treatment at a young age can reverse social impairments. But the same intervention was not effective at an older age. The study is the first to shed light on the crucial timing of therapy to improve social impairments in a condition associated with ... Read More about Earlier treatment may help reverse autism-like behavior in tuberous sclerosis
In zebrafish, a way to find new cancer therapies, targeting tumor promoters
The lab of Leonard Zon, MD, has long been interested in making blood stem cells in quantity for therapeutic purposes. To test for their presence in zebrafish, their go-to research model, they turned to the MYB gene, a marker of blood stem cells. To spot the cells, Joseph Mandelbaum, a PhD candidate in the lab, attached a fluorescent ... Read More about In zebrafish, a way to find new cancer therapies, targeting tumor promoters
Tracking the elusive genes that cause strabismus
Strabismus is a common condition in which the eyes do not align properly, turning inward, outward, upward or downward. Two to four percent of children have some form of it. Some cases can be treated with glasses or eye patching; other cases require eye muscle surgery. But the treatments don’t address the root causes of strabismus, which ... Read More about Tracking the elusive genes that cause strabismus
A perfect genetic hit: New gene mutation implicated in rare congenital diarrhea
When the 1-year-old boy arrived from overseas, he was relying on total parenteral nutrition — a way of bypassing the digestive system to provide nutrients and calories completely intravenously — to survive. From the time of his birth, he had experienced unexplainable diarrhea. Answers were desperately needed. Sequencing his genes in search of clues, neonatologists ... Read More about A perfect genetic hit: New gene mutation implicated in rare congenital diarrhea